The RAPS learning platform provider will be upgrading its security posture. This will take the system off-line from 20 July through the end of the day 23 July. This will affect any Online Course, eBook, and Virtual Program Attendance. Thank you for your patience.
Posted 01 April 2010 | By
A recent study by the Tufts Center for the Study of Drug Development (CSDD) found that the workload for regulatory professionals at pharmaceutical and biotechnology companies has increased dramatically over the last decade. Based on data from mid-size and large pharmaceutical and biotechnology companies with global drug development operations, the study also found that regulatory functions support, on average, 100 major projects per year, two-thirds of which are in clinical research phases.1